Quercetin inhibits amyloid fibrillation of bovine insulin and destabilizes preformed fibrils

Biochemical and Biophysical Research Communications

Volumn 415, Issue 4, 2011, Pages 675-679

  Wang, Jian Bo ^a   Wang, Yi Min ^a   Zeng, Cheng Ming ^a  

^a SHAANXI NORMAL UNIVERSITY   (China)

Author keywords

Amorphous aggregates; Amyloid fibrils; Cytoskeletal proteins; Hemolysis; Insulin; Quercetin

Indexed keywords

AMYLOID PROTEIN; BOVINE INSULIN; CYTOSKELETON PROTEIN; QUERCETIN;

ANTIAMYLOIDOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ERYTHROCYTE MEMBRANE; FIBER; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STABILITY; PROTEIN STRUCTURE;

AMYLOID; ANIMALS; CATTLE; ERYTHROCYTES; HEMOLYSIS; HUMANS; INSULIN; PROTEIN STABILITY; QUERCETIN;

BOVINAE;

EID: 84855895850     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.135     Document Type: Article

References (31)

1. Dobson C.M. Protein folding and misfolding. Nature 2003, 426:884-890.
2. Stefani M. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim. Biophys. Acta 2004, 1739:5-25.
3. Krebs M.H., Bromley E.C., Donald A.M. The binding of thioflavin-T to amyloid fibrils: localization and implications. J. Struct. Biol. 2005, 149:30-37.
4. Ahmad A., Millett I.S., Doniach S., Uversky V.N., Fink A.L. Partially folded intermediates in insulin fibrillation. Biochemistry 2003, 42:1404-11416.
5. Hua Q.X., Weiss M.A. Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J. Biol. Chem. 2004, 279:21449-21460.
6. Green N.S., Foss T.R., Kelly J.W. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis. Proc. Natl. Acad. Sci. USA 2005, 102:14545-14550.
7. Ehrnhoefer D.E., Bieschke J., Boeddrich A., Herbst M., Masino L., Lurz R., Engemann S., Pastore A., Wanker E.E. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 2008, 15:558-566.
8. Akaishi T., Morimotoa T., Shibaoa M., Watanabea S., Sakai-Katob K., Utsunomiya-Tateb N., Abea K. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid β protein. Neurosci. Lett. 2008, 444:280-285.
9. Chirumbolo S. The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm. Allergy Drug Targets 2010, 9:263-285.
10. Jagtap S., Meganathan K., Wagh V., Winkler J., Hescheler J., Sachinidis A. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr. Med. Chem. 2009, 16:1451-1462.
11. Ansari M.A., Abdul H.M., Joshi G., Opii W.O., Butterfield D.A. Protective effect of quercetin in primary neurons against Abeta (1-42): relevance to Alzheimer's disease. J. Nutr. Biochem. 2009, 20:269-275.
12. Matsuzaki K., Noguch T., Wakabayashi M., Ikeda K., Okada T., Ohashi Y., Hoshino M., Naiki H. Inhibitors of amyloid β-protein aggregation mediated by GM1-containing raft-like membranes. Biochim. Biophys. Acta 2007, 1768:122-130.
13. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 2003, 87:172-181.
14. da Silva M.A., Arruda M.A. Mechanization of the Bradford reaction for the spectrophotometric determination of total proteins. Anal. Biochem. 2006, 351:155-157.
15. Whittingham J.L., Scott D.J., Chance K., Wilson A., Finch J., Brange J., Dodson G.G. Insulin at pH 2: structural analysis of the conditions promoting insulin fiber formation. J. Mol. Biol. 2002, 318:479-490.
16. Huang B., He J., Ren J., Yan X.Y., Zeng C.M. Cellular membrane disruption by amyloid fibrils involved intermolecular disulfide cross-linking. Biochemistry 2009, 48:5794-5800.
17. He J., Lin J., Li J., Zhang J.H., Sun X.M., Zeng C.M. Dual effects of Ginkgo biloba leaf extract on human red blood cells. Basic Clin. Pharm. Toxicol. 2009, 104:138-144.
18. Chen R., Wang J.B., Zhang X.Q., Zeng C.M. Green tea polyphenol epigallocatechin-3-gallate (EGCG) induced intermolecular cross-linking of membrane proteins. Arch. Biochem. Biophys. 2011, 507:343-349.
19. Fändrich M. Absolute correlation between lag time and growth rate in the spontaneous formation of several amyloid-like aggregates and fibrils. J. Mol. Biol. 2007, 365:1266-1270.
20. Ahmad A., Uversky V.N., Hong D., Fink A.L. Early events in the fibrillation of monomeric insulin. J. Biol. Chem. 2005, 280:42669-42675.
21. Richard T., Lefeuvre D., Descendit A., Quideau S., Monti J.P. Recognition characters in peptide-polyphenol complex formation. Biochim. Biophys. Acta 2008, 1760:951-958.
22. Siebert K.J., Troukhanova N.V., Lynn P.Y. Nature of polyphenol-protein interactions. J. Agric. Food Chem. 1996, 44:80-85.
23. He J., Xing Y.F., Huang B., Zhang Y.Z., Zeng C.M. Tea catechins induced the conversion of preformed lysozyme amyloid fibrils to amorphous aggregates. J. Agric. Food Chem. 2009, 57:11391-11396.
24. Bieschke J., Russ J., Friedrich R.P., Ehrnhoefer D.E., Wobst H., Neugebauer K., Wanker E.E. EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. USA 2010, 107:7710-7715.
25. 42 protofibrils with morin: mechanistic insights from molecular dynamics simulations. Biochemistry 2010, 49:3935-3946.
26. Porat Y., Abramowitz A., Gazit E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug Des. 2006, 67:27-37.
27. Levy-sakin M., Shreberk M., Daniel Y., Gazit E. Targeting insulin amyloid assembly by small aromatic molecules: toward rational design of aggregation inhibitors. Islets 2009, 1:210-215.
28. Hirohata M., Hasegawa K., Tsutsumi-Yasuhara S., Ohhashi Y., Ookoshi T., Ono K., Yamada M., Naiki H. The anti-amyloidogenic effect is exerted against Alzheimer's β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 2007, 46:1888-1899.
29. Shoval H., Weiner L., Gazit E., Levy M., Pinchuk I., Lichtenberg D. Polyphenol-induced dissociation of various amyloid fibrils results in a methionine-independent formation of ROS. Biochim. Biophys. Acta 2008, 1784:1570-1577.
30. Rattanajarasroj S., Unchern S. Comparable attenuation of Abeta(25-35)-induced neurotoxicity by quercitrin and 17beta-estradiol in cultured rat hippocampal neurons. Neurochem. Res. 2010, 35:1196-1205.
31. Kim J., Lee H.J., Lee K.W. Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J. Neurochem. 2010, 112:1415-1430.